| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Tenormin submite - T | 30 Tablet(s) | 2.64 | 12.05 | 20 % | | Tablets: Atenololum 25 mg | Atnahs Pharma
Switzerland AG | B / SL / SO | FB | | G |  |
| | | IP | CI | | Tenormin submite - T | 100 Tablet(s) | 7.81 | 17.65 | 20 % | | Tablets: Atenololum 25 mg | Atnahs Pharma
Switzerland AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Tenormin mite - T | 30 Tablet(s) | 4.45 | 14.05 | 20 % | | Tablets: Atenololum 50 mg | Atnahs Pharma
Switzerland AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Tenormin mite - T | 100 Tablet(s) | 14.28 | 31.80 | 20 % | | Tablets: Atenololum 50 mg | Atnahs Pharma
Switzerland AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Tenormin - T | 30 Tablet(s) | 7.46 | 17.25 | 20 % | | Tablets: Atenololum 100 mg | Atnahs Pharma
Switzerland AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Tenormin - T | 100 Tablet(s) | 24.73 | 43.05 | 20 % | | Tablets: Atenololum 100 mg | Atnahs Pharma
Switzerland AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Atenil submite | 20 Tablet(s) | 2.06 | 11.45 | 10 % | | Coated tablets: Atenololum 25 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenil submite | 100 Tablet(s) | 6.51 | 16.30 | 10 % | | Coated tablets: Atenololum 25 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenil mite | 20 Tablet(s) | 3.13 | 12.65 | 10 % | | Coated tablets: Atenololum 50 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenil mite | 100 Tablet(s) | 12.31 | 29.75 | 10 % | | Coated tablets: Atenololum 50 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenil | 20 Tablet(s) | 4.06 | 13.65 | 10 % | | Coated tablets: Atenololum 100 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenil | 100 Tablet(s) | 20.84 | 39.05 | 10 % | | Coated tablets: Atenololum 100 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenolol-Mepha 25 ‐ I | 30 Tablet(s) | 2.06 | 11.45 | 10 % | | Coated tablets: Atenololum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenolol-Mepha 25 ‐ I | 100 Tablet(s) | 6.51 | 16.30 | 10 % | | Coated tablets: Atenololum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenolol-Mepha 50 | 30 Tablet(s) | 4.11 | 13.70 | 10 % | | Coated tablets: Atenololum 50 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenolol-Mepha 50 | 100 Tablet(s) | 11.20 | 28.65 | 10 % | | Coated tablets: Atenololum 50 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenolol-Mepha 100 | 30 Tablet(s) | 6.10 | 15.85 | 10 % | | Coated tablets: Atenololum 100 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Atenolol-Mepha 100 | 100 Tablet(s) | 19.50 | 37.65 | 10 % | | Coated tablets: Atenololum 100 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Selobloc 50 mg | 30 | PR | PR | k.A. | | Coated tablets: Atenololum 50 mg | Lagap SA | B | FB | | G | |
| | | IP | CI | | Selobloc 50 mg | 100 | PR | PR | k.A. | | Coated tablets: Atenololum 50 mg | Lagap SA | B | FB | | G | |
| | | IP | CI | | Selobloc 100 mg | 30 | PR | PR | k.A. | | Coated tablets: Atenololum 100 mg | Lagap SA | B | FB | | G | |
| | | IP | CI | | Selobloc 100 mg | 100 | PR | PR | k.A. | | Coated tablets: Atenololum 100 mg | Lagap SA | B | FB | | G | |
| | | IP | CI | | Tenormin | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Atenololum | AstraZeneca AG | B | FB | | G | |
| | | | | | Atenolol-Cophar 25 | 10 Coated tablet(s) | 1.41 | 3.40 | k.A. | | Dragées: Atenololum 25 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 25 | 30 Coated tablet(s) | 3.65 | 8.80 | k.A. | | Dragées: Atenololum 25 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 25 | 100 Coated tablet(s) | 11.27 | 25.55 | k.A. | | Dragées: Atenololum 25 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 50 | 10 Coated tablet(s) | 2.34 | 5.65 | k.A. | | Dragées: Atenololum 50 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 50 | 30 Coated tablet(s) | 6.04 | 13.25 | k.A. | | Dragées: Atenololum 50 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 50 | 100 Coated tablet(s) | 18.57 | 38.25 | k.A. | | Dragées: Atenololum 50 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 100 | 10 Coated tablet(s) | 3.99 | 9.60 | k.A. | | Dragées: Atenololum 100 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 100 | 30 Coated tablet(s) | 11.11 | 25.35 | k.A. | | Dragées: Atenololum 100 mg | Cophar SA | B | FB | | G | |
| | | | | | Atenolol-Cophar 100 | 100 Coated tablet(s) | 37.04 | 60.00 | k.A. | | Dragées: Atenololum 100 mg | Cophar SA | B | FB | | G | |
| | | | | | Atesifar 50 mg | 30 Coated tablet(s) | PR | PR | k.A. | | Coated tablets: Atenololum 50 mg | Siphar SA | B | FB | | G | |
| | | | | | Atesifar 50 mg | 100 Coated tablet(s) | PR | PR | k.A. | | Coated tablets: Atenololum 50 mg | Siphar SA | B | FB | | G | |
| | | | | | Atesifar 100 mg | 30 Coated tablet(s) | PR | PR | k.A. | | Coated tablets: Atenololum 100 mg | Siphar SA | B | FB | | G | |
| | | | | | Atesifar 100 mg | 100 Coated tablet(s) | PR | PR | k.A. | | Coated tablets: Atenololum 100 mg | Siphar SA | B | FB | | G | |
